# US 2012/0252870 A1 · Indian Hedgehog (Ihh) as a Marker to Predict Osteoarthritis (OA) and Methods for the Prevention and Treatment of OA

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252870 A1
- Document ID: US20120252870A1
- Status: Published application
- Kind: A1
- Application number: 13/400,011
- Filed: 2012-02-17
- Published: 2012-10-04
- Earliest claimed: 2011-02-19
- Assignees: Rhode Island Hospital
- Inventors: Lei Wei
- Web page: https://patentgrep.com/patent/US20120252870A1

## CPC

- A61K 31/343: condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A61K 31/27: of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A61K 31/565: not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K 31/58: containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin (digitoxin {A61K31/7048})
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 1/6888: for detection or identification of organisms
- G01N 33/6887: {from muscle, cartilage or connective tissue}
- C12Q 2600/136: Screening for pharmacological compounds
- G01N 2800/105: Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Methods of diagnosing osteoarthritis are carried out by measuring levels of Ihh, and methods of treating osteoarthritis comprise inhibiting Ihh to reduce or prevent cartilage degradation.

## Claims

### Claim 1

A method of diagnosing or predicting the development of osteoarthritis, comprising detecting the presence of an Indian hedgehog (Ihh) gene product in a bodily fluid, wherein an increase a level of said gene product compared to a normal level indicates a diagnosis of osteoarthritis or a prediction of development of osteoarthritis.

### Claim 2 (depends on 1)

The method of claim 1, wherein said gene product comprises a polypeptide, protein, or transcript.

### Claim 3 (depends on 1)

The method of claim 1, wherein said bodily fluid comprises synovial fluid, blood, or serum.

### Claim 4 (depends on 1)

The method of claim 1, wherein said level of said gene product correlates with the severity of osteoarthritis.

### Claim 5

A method of inhibiting cartilage damage in a subject, comprising identifying an injured or diseased joint, and contacting a tissue of said joint with an inhibitor of an Ihh gene product.

### Claim 6 (depends on 5)

The method of claim 5, wherein said tissue is contacted by injecting or infusing said inhibitor into a joint space of said joint.

### Claim 7 (depends on 5)

The method of claim 5, wherein said tissue is contacted by injecting or infusing said inhibitor into a synovium of said joint.

### Claim 8 (depends on 5)

The method of claim 5, wherein said joint comprises a knee, elbow, hip, or shoulder joint.

### Claim 9 (depends on 5)

The method of claim 5, wherein said inhibitor is administered arthroscopically.

### Claim 10 (depends on 5)

The method of claim 5, wherein said inhibitor comprises a siRNA.

### Claim 11 (depends on 5)

The method of claim 5, wherein said inhibitor is a small molecule inhibitor.

### Claim 12 (depends on 11)

The method of claim 11, wherein said small molecule inhibitor is selected from the group consisting of:
